Notably, TNFRSF6B and CLEC16A, a less characterized gene in AD pathogenesis, have shown consistent associations with the disease across European and Asian ancestries, enhancing their critical role as immunomodulatory agents in the cutaneous disorder [37]. This evidence concerns the gene CLEC16A and skin disorder.